CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 104 filers reported holding CULLINAN ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61 | -15.3% | 6,757 | +0.8% | 0.00% | – |
| Q2 2023 | $72 | -50.7% | 6,705 | -53.0% | 0.00% | – |
| Q1 2023 | $146 | -39.9% | 14,253 | -38.2% | 0.00% | – |
| Q4 2022 | $243 | -99.9% | 23,067 | +0.0% | 0.00% | – |
| Q3 2022 | $296,000 | +31.6% | 23,063 | +31.2% | 0.00% | – |
| Q2 2022 | $225,000 | +35.5% | 17,584 | +10.9% | 0.00% | – |
| Q1 2022 | $166,000 | -34.4% | 15,850 | -3.5% | 0.00% | – |
| Q4 2021 | $253,000 | -5.2% | 16,425 | +38.6% | 0.00% | – |
| Q3 2021 | $267,000 | -12.2% | 11,848 | +0.4% | 0.00% | – |
| Q2 2021 | $304,000 | -13.1% | 11,804 | +40.5% | 0.00% | – |
| Q1 2021 | $350,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |